CMTX-101

N/A

Report date: 2023/12/08 20:04:42

Base Information

Drug NameCMTX-101
Drug Alias NameCMTX-101CMTX-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBacterial biofilms inhibitorsDNA-binding proteins modulators
TargetsDNA-binding proteins
Therapy Area/IndicationsCommunity Acquired PneumoniaCystic FibrosisPneumonia, Bacterial +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesClarametyx Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesClarametyx Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCystic FibrosisPneumonia, BacterialInfections
Inactive IndicationsCommunity Acquired Pneumonia

Other Information

ATC CodeN/A
Related LinksN/A